$VHC
VirnetX Holding Corp

2023 Q2 Form 10-Q Financial Statement

#000114036123024691 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $2.000K $2.000K $5.000K
YoY Change -94.12% -60.0% 0.0%
Cost Of Revenue $0.00 $0.00 -$4.000K
YoY Change -100.0% -99.96%
Gross Profit $2.000K $2.000K $9.000K
YoY Change -94.12% -77.78% -99.9%
Gross Profit Margin 100.0% 100.0% 180.0%
Selling, General & Admin $7.366M $4.548M $3.185M
YoY Change 141.83% 42.79% -92.41%
% of Gross Profit 368300.0% 227400.0% 35388.89%
Research & Development $4.755M $1.368M $1.227M
YoY Change 278.88% 11.49% 6.51%
% of Gross Profit 237750.0% 68400.0% 13633.33%
Depreciation & Amortization $2.000K $1.000K $2.000K
YoY Change 100.0% -50.0%
% of Gross Profit 100.0% 50.0% 22.22%
Operating Expenses $12.12M $5.916M $4.408M
YoY Change 181.82% 34.21% -86.9%
Operating Profit -$12.12M -$5.914M -$4.403M
YoY Change 184.02% 34.32% -86.92%
Interest Expense $740.0K $1.369M $24.00K
YoY Change 264.53% 5604.17%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$11.38M -$4.545M -$4.379M
YoY Change 180.0% 3.79% -86.98%
Income Tax $0.00 -$78.00K -$1.059M
% Of Pretax Income
Net Earnings -$11.38M -$4.467M -$3.320M
YoY Change 156.46% 34.55% -87.44%
Net Earnings / Revenue -568950.0% -223350.0% -66400.0%
Basic Earnings Per Share -$0.16 -$0.06 -$0.05
Diluted Earnings Per Share -$0.16 -$0.06 -$0.05
COMMON SHARES
Basic Shares Outstanding 71.42M 71.42M 71.23M
Diluted Shares Outstanding 71.47M 71.43M 71.23M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.23M $149.4M $165.1M
YoY Change -59.03% -9.52% -23.9%
Cash & Equivalents $25.97M $97.05M $136.4M
Short-Term Investments $40.26M $52.37M $28.73M
Other Short-Term Assets $480.0K $614.0K $660.0K
YoY Change -6.61% -6.97% -81.14%
Inventory
Prepaid Expenses
Receivables $4.000K $4.000K $12.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $66.71M $150.0M $165.8M
YoY Change -58.87% -9.51% -24.8%
LONG-TERM ASSETS
Property, Plant & Equipment $8.000K $10.00K $16.00K
YoY Change -46.67% -37.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $19.00K $10.00K $17.98M
YoY Change -99.89% -99.94% 2.73%
Total Long-Term Assets $534.0K $624.0K $17.99M
YoY Change -96.95% -96.53% 2.82%
TOTAL ASSETS
Total Short-Term Assets $66.71M $150.0M $165.8M
Total Long-Term Assets $534.0K $624.0K $17.99M
Total Assets $67.25M $150.7M $183.8M
YoY Change -62.58% -18.03% -22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $397.0K $1.692M $651.0K
YoY Change 13.43% 159.91% 30.2%
Accrued Expenses $392.0K $71.79M $330.0K
YoY Change 17.72% 21655.76% -99.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $813.0K $73.52M $1.037M
YoY Change 10.16% 6989.97% -97.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $31.00K
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $31.00K
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $813.0K $73.52M $1.037M
Total Long-Term Liabilities $0.00 $0.00 $31.00K
Total Liabilities $813.0K $73.52M $1.068M
YoY Change 7.54% 6784.18% -97.27%
SHAREHOLDERS EQUITY
Retained Earnings -$174.5M -$163.1M -$54.26M
YoY Change 200.6%
Common Stock $7.000K $7.000K $7.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.43M $77.14M $182.7M
YoY Change
Total Liabilities & Shareholders Equity $67.25M $150.7M $183.8M
YoY Change -62.58% -18.03% -22.77%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$11.38M -$4.467M -$3.320M
YoY Change 156.46% 34.55% -87.44%
Depreciation, Depletion And Amortization $2.000K $1.000K $2.000K
YoY Change 100.0% -50.0%
Cash From Operating Activities -$11.75M -$2.711M -$3.962M
YoY Change 252.58% -31.57% -5.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $12.11M $13.20M -$1.648M
YoY Change -306.39% -900.97% -119.39%
Cash From Investing Activities $12.11M $13.20M -$1.648M
YoY Change -306.39% -900.97% -119.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -71.43M 0.000
YoY Change 246224.14%
NET CHANGE
Cash From Operating Activities -11.75M -2.711M -3.962M
Cash From Investing Activities 12.11M 13.20M -1.648M
Cash From Financing Activities -71.43M 0.000
Net Change In Cash -71.08M 10.49M -5.610M
YoY Change 670.1% -286.97% -230.47%
FREE CASH FLOW
Cash From Operating Activities -$11.75M -$2.711M -$3.962M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001082324
CY2023Q1 vhc Licensing Costs
LicensingCosts
0
CY2022Q1 vhc Licensing Costs
LicensingCosts
-4000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
152244000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
185449000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
77136000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
182733000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3320000
CY2023Q1 us-gaap Dividends Cash
DividendsCash
71429000
CY2022Q1 us-gaap Dividends Cash
DividendsCash
0
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71425000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71233000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 vhc Concentration Risk Number Of Financial Institutions
ConcentrationRiskNumberOfFinancialInstitutions
2
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4467000
CY2023Q1 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
149605000
CY2023Q1 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
149417000
CY2022Q4 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
152400000
CY2022Q4 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
152023000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-78000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4545000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0171
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1059000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4379000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2445
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71425000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71233000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7353129
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6931592

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
vhc-20230331_cal.xml Edgar Link unprocessable
vhc-20230331_def.xml Edgar Link unprocessable
vhc-20230331_lab.xml Edgar Link unprocessable
0001140361-23-024691-index-headers.html Edgar Link pending
0001140361-23-024691-index.html Edgar Link pending
0001140361-23-024691.txt Edgar Link pending
0001140361-23-024691-xbrl.zip Edgar Link pending
brhc20052553_10q.htm Edgar Link pending
brhc20052553_ex10-2.htm Edgar Link pending
brhc20052553_ex31-1.htm Edgar Link pending
brhc20052553_ex31-2.htm Edgar Link pending
brhc20052553_ex32-1.htm Edgar Link pending
brhc20052553_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
image00002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vhc-20230331.xsd Edgar Link pending
vhc-20230331_pre.xml Edgar Link unprocessable
brhc20052553_10q_htm.xml Edgar Link completed